0001193125-14-237917.txt : 20140717 0001193125-14-237917.hdr.sgml : 20140717 20140616171959 ACCESSION NUMBER: 0001193125-14-237917 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZAFGEN, INC. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617 ) 401-3051 MAIL ADDRESS: STREET 1: ONE BROADWAY, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 CORRESP 1 filename1.htm UW Acceleration Request for Zafgen

June 16, 2014

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Zafgen, Inc.
     Registration Statement on Form S-1 (SEC File No. 333-195391)

Ladies and Gentlemen:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Zafgen, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern time, on June 18, 2014 or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 1,315 copies of the Preliminary Prospectus dated June 5, 2014 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others.

In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

Very truly yours,

 

LEERINK PARTNERS LLC

COWEN AND COMPANY, LLC

 

    As Representatives

 

By:     LEERINK PARTNERS LLC

By:   /s/ Jon Civitarese

Name:

Title:

  

Jon Civitarese

Managing Director

 

By:     COWEN AND COMPANY, LLC
By:   /s/ Jason Fenton

Name:

Title:

  

Jason Fenton

Managing Director